Clinical Trial Results:
Estudio aleatorizado, doble ciego, controlado con placebo, de grupos paralelos, para determinar si la adición de Aliskiren al tratamiento convencional, en pacientes con diabetes tipo 2 y alto riesgo de eventos cardiovasculares y renales, reduce la morbilidad y mortalidad de origen cardiovascular y renal respecto al tratamiento convencional
Summary
|
|
EudraCT number |
2007-000860-25 |
Trial protocol |
ES PT FR FI GR DE DK GB LT BE HU NL AT SE CZ IT SK |
Global completion date |
06 Feb 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Apr 2016
|
First version publication date |
16 Apr 2016
|
Other versions |
|
Summary report(s) |
CZOL446H2409 CT.gov results public |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.